Skip To Main Content
Bruce F Bebo on Muck Rack

Bruce F Bebo

Portland
As seen in: Nature, WebMD, SAGE Publishing, Neurology, NeurologyLive, NotiUlti, Momentum (NMSS), cn1699.com
National psoriasis Foundation Research Department
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Bruce F

Contact Bruce F, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Towards a biologically informed description of multiple sclerosis disease course — a roadmap for transition

|
By Fred Lublin, Lindsay Rechtman, James Quinn, Maria amato, Bruce F Bebo, Peter A Calabresi, Julie Fiol, Marcia Finlayson, Annie Hawton, Tanja Kuhlmann, Ruth Ann Marrie, Marcello Moccia, Xavier Montalban, Michael Panzara, Kathy Smith, Maria Pia Sormani, Jon Strum, Barbara G. Vickrey, Timothy Coetzee
| Nature Verified
Abstract Contemporary management of multiple sclerosis is based on the clinical course descriptors of relapsing–remitting, secondary progressive and primary progressive. However, recognition is growing in the field that these clinical course descriptors do not capture the full disease spectrum of multiple sclerosis or reflect the underlying biological mechanisms of disease, and that biologically informed course descriptors are needed.
Open in Who Shared Issue with article?

The refined Pathways to Cures Research Roadmap for multiple sclerosis cures

|
By Bruce F Bebo, Brenda Banwell, Caroline C. Whitacre, Timothy Coetzee
| SAGE Publishing
Skip to main content Intended for healthcare professionals Get full access to this article View all access and purchase options for this article. Data availability statement Data sharing not applicable to this article as no datasets were generated or analyzed during the current study. References 1. Walton C, King R, Rechtman L, et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler 2020; 26(14): 1816–1821. 2.
Open in Who Shared Issue with article?

The refined Pathways to Cures Research Roadmap for multiple sclerosis cures

|
By Bruce F Bebo, Brenda Banwell, Caroline C. Whitacre, Timothy Coetzee
| SAGE Publishing
Introduction Multiple sclerosis (MS) is a chronic immune-mediated disease of the central nervous system (CNS) affecting nearly 3 million people worldwide that can cause significant disability.1 Although much progress has been made in understanding the pathogenesis of MS and there are many effective treatments for relapsing disease, strategies that prevent incident cases do not yet exist, there is a paucity of therapies that slow disability progression or restore function, and cures for MS...
Open in Who Shared Issue with article?
See all 15 licensed articles (30 Total)